Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study.

MLA

Sbraccia, Paolo, et al. “Investigating the Potential Non‐authorized Use of Two Different Formulations of Liraglutide in Europe: A Real‐world Drug Utilization Study.” Diabetes, Obesity & Metabolism, vol. 25, no. 4, Apr. 2023, pp. 985–91. EBSCOhost, https://doi.org/10.1111/dom.14945.

APA

Sbraccia, P., Aberle, J., Olsen, A. H., Rathor, N., & Major, P. A. (2023). Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study. Diabetes, Obesity & Metabolism, 25(4), 985–991. https://doi.org/10.1111/dom.14945

Chicago

Sbraccia, Paolo, Jens Aberle, Anne Helene Olsen, Naveen Rathor, and Pedersen, Atheline Major. 2023. “Investigating the Potential Non‐authorized Use of Two Different Formulations of Liraglutide in Europe: A Real‐world Drug Utilization Study.” Diabetes, Obesity & Metabolism 25 (4): 985–91. doi:10.1111/dom.14945.